Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 216 results
A tissue sample on a microscope slide in a laboratory setting.

Jun 26, 2026

AI in Diagnostics Market to Reach USD 9.7 Billion by 2033, Driven by Rising Demand for Faster and More Accurate Disease Detection

The global market for artificial intelligence in diagnostics is poised for significant growth, projected to reach USD 9.7 billion by 2033, driven by the increasing demand for rapid and precise disease detection.The artificial intelligence (AI) diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 21.7% between 2026 and 2033, reflecting the surging adoption of AI-powered diagnostic tools. As healthcare systems worldwide seek to enhance early detection and accuracy, AI
Echocardiogram machine in a dimly lit clinical room

Jun 26, 2026

EIQ (ASX:EIQ): Why This Healthcare AI Partnership Has the Market Watching Closely

EchoIQ's recent partnership with Pro Medicus has positioned it at the forefront of healthcare technology discussions, particularly in the realm of cardiovascular diagnostics powered by artificial intelligence. This collaboration underscores the increasing importance of AI in enhancing diagnostic capabilities within the healthcare sector.As the Australian healthcare technology landscape evolves rapidly, EchoIQ stands out by leveraging AI to assist clinicians in identifying serious cardiovascular
A minimalist representation of a breast silhouette with a mammogram overlay in flat design.

Jun 24, 2026

FUJIFILM India Unveils First AI-Powered Digital Mammography System at NM Medical in Mumbai

FUJIFILM India has launched its first AI-driven digital mammography system, AMULET SOPHINITY, at NM Medical in Mumbai, marking a significant advancement in diagnostic imaging technology in the region.This innovative system combines AI capabilities with high-definition imaging to enhance the mammography experience for both patients and healthcare professionals. Key features include a 50 μm direct conversion detector that offers high-resolution images while minimizing radiation exposure, and tomos
Silhouette of a fetus with ultrasound waves

Jun 24, 2026

BrightHeart announces CE Mark and European launch of its AI platform for Prenatal Ultrasound

BrightHeart has achieved a significant milestone by securing the CE mark for its B-Right AI Platform, facilitating its European launch. This advancement will be showcased at the upcoming Fetal Medicine Foundation (FMF) World Congress in Vienna in June 2026.The B-Right AI Platform aims to enhance the accuracy of prenatal ultrasounds, which are often challenging due to the complexities involved in evaluating numerous fetal structures within a limited timeframe. Current detection rates for congenit
A digital wound measurement device in a hospital setting during blue hour.

Jun 24, 2026

Digital Wound Measurement Devices | Are Software and Connectivity Becoming Table-Stakes?

The digital wound measurement devices market is poised for significant growth, projected to expand from USD 1.2 billion in 2026 to USD 2.0 billion by 2036, reflecting a compound annual growth rate (CAGR) of 5.2%. This growth is largely driven by the rising prevalence of chronic wounds, particularly diabetic ulcers, which are expected to dominate market demand.The healthcare sector is increasingly prioritizing integrated solutions that enhance wound management through automated documentation, rem
A breast tissue sample in a lab setting

Jun 24, 2026

Spotlight Medical lands IVDR CE Mark for AI Breast Cancer Test

Spotlight Medical has achieved a significant regulatory milestone with the CE marking of its AI-driven breast cancer test, myStage Dx, under the EU In Vitro Diagnostic Medical Devices Regulation (IVDR).This approval marks a crucial step in the company's strategy to expand its market presence in Europe, allowing myStage Dx to be implemented in oncology centers and pathology labs. The test aims to enhance risk stratification for patients with ER+/HER2− early breast cancer, addressing the limitatio
Minimalist illustration of a T-cell and breast tissue sample

Jun 23, 2026

New AI Diagnostics and Environmental Data Reshape Cancer Care and Risk Assessment

Recent advancements in AI diagnostics and emerging environmental data are significantly reshaping cancer care and risk assessment.A groundbreaking study published in *Nature Communications* has revealed that analyzing immune cell density, specifically the presence of cytotoxic T-cells, can help identify early-stage breast cancer patients who may not require chemotherapy. Conducted by researchers at RCSI University of Medicine and Health Sciences and University College Dublin, this AI-driven appr
A digital pathology scanner in a laboratory setting

Jun 23, 2026

Versant Diagnostics, Leica Biosystems Expand Collaboration with Aperio GT Elite Deployment

Leica Biosystems and Versant Diagnostics are enhancing their partnership to promote digital pathology through the deployment of the Aperio GT Elite solution, marking a significant advancement in laboratory technology.This collaboration has led to PRW Laboratories becoming the first facility globally to implement the Aperio GT Elite, a high-throughput digital pathology scanner designed for efficient slide processing. The scanner can rapidly process slides in as little as 22 seconds, integrating L
A radiopharmaceutical vial in a dimly lit hospital corridor

Jun 23, 2026

Synektik strategy in medical imaging, shares on Warsaw radar

Synektik, a Polish healthcare technology company, is solidifying its presence in the medical imaging sector, particularly in radiopharmaceuticals, as it aligns with long-term trends in hospital investments and AI diagnostics across Europe.Operating primarily on the Warsaw Stock Exchange, Synektik focuses on advanced imaging systems and radiopharmaceuticals, particularly for cardiology and oncology. The company is strategically positioned in Central Europe, catering to hospitals that are ramping
Minimalist illustration of an ultrasound scanner with chip module

Jun 19, 2026

AI Medical Tech Stock Butterfly Network (NYSE: BFLY) Makes NYSE Top Gainer List Two Days in a Row

Butterfly Network (NYSE: BFLY) has achieved remarkable stock gains, topping the NYSE gainers list for two consecutive days, with a nearly 56% increase attributed to its involvement in Midjourney's innovative full-body ultrasound scanner.The surge in Butterfly Network's stock price, now at $8.90, follows the announcement of its collaboration with Midjourney Medical, which unveiled a groundbreaking imaging system designed to enhance health awareness and preventive care. The scanner integrates 40 B
A diagnostic scan on a clinical desk with an imaging display in the background.

Jun 19, 2026

NHS to transform scan access for 6.6 million people in major tech initiative

The NHS is embarking on a groundbreaking initiative aimed at revolutionizing diagnostic imaging access for 6.6 million people in the West Midlands.The Converged Digital Imaging Platform will establish a unified diagnostic imaging record for every patient in the region. This initiative is poised to enhance the quality of diagnoses by ensuring that patients, regardless of their location, have access to expert interpretations of their scans. By facilitating earlier diagnosis and treatment for condi
A pathology slide on a lab bench in a dimly lit laboratory

Jun 19, 2026

From single-tumour to pan-cancer AI diagnostics

The advancement of AI in cancer diagnostics is shifting from single-tumor analyses to more comprehensive, pan-cancer approaches. This evolution is driven by the integration of advanced algorithms and large language models into clinical workflows.Dr. Tolkach highlighted how diagnostic algorithms in pathology and oncology have progressed significantly, moving from basic diagnostic functions to sophisticated prognostic and predictive models. This shift is now being further enhanced by the use of mu